Late-Breaking ASCO Data Demonstrate Circulating Tumor Cells As Potential Biomarker for Metastatic Prostate Cancer Clinical Trials - Drugs.com MedNews
Links shared publicly online about this topic.
- 235total visits
Late-Breaking ASCO Data Demonstrate Circulating Tumor Cells As Potential Biomarker for Metastatic Prostate Cancer Clinical Trials - Drugs.com MedNews
- Study utilized Veridex s CELLSEARCH CTC Test, the only regulatory-cleared in vitro diagnostic test to capture and count CTCs - - Additional data presented at
View full resource at drugs.com
Tags: Cancer, Prostate Cancer, Prostate, Drug, Clinical Trial, Men's Health
Most Recently Shared on June 7, 2011 at 10:03 pm By:
Late-Breaking ASCO Data Demonstrate Circulating Tumor Cells As Potential Biomarker for Metastatic Prostate... http://bit.ly/jhvS9i #drug
Advertisement
